NKG2D is an activating receptor expressed on T and NK cells which recognizes a group of ligands (NKG2D-L) which are upregulated in malignant transformation, including AML, and they are barely expressed on healthy tissues (Hilpert et al., 2012). Here, KLRK1 is linked to acute myeloid leukemia.